![Cathy Nolan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Cathy Nolan worked as a Senior Vice President-Strategy & Marketing at Aimmune Therapeutics, Inc. from 2020 to 2022.
Precedenti posizioni note di Cathy Nolan
Società | Posizione | Fine |
---|---|---|
AIMMUNE THERAPEUTICS, INC. | Vendite & Marketing | 01/11/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Aimmune Therapeutics, Inc.
![]() Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Borsa valori
- Insiders
- Cathy Nolan